Nivolumab combined with brentuximab vedotin with or without mediastinal radiotherapy for relapsed/refractory primary mediastinal large B-cell lymphoma

Haematologica. 2024 May 2. doi: 10.3324/haematol.2023.284689. Online ahead of print.ABSTRACTNot available.PMID:38695142 | DOI:10.3324/haematol.2023.284689

Source: Haematologica - May 2, 2024 Category: Hematology Authors: Loic Renaud Juliette Wencel Arnaud Pag ès Ahmad Al Jijakli Hannah Moatti Laurent Quero Vincent Camus Pauline Brice Source Type: research